How biocompatible haemodialysers can conquer the need for systemic anticoagulation even in post-dilution haemodiafiltration: a cross-over study

BACKGROUND: While systemic anticoagulation is most widely used in haemodialysis (HD), contraindications to its use might occur in particular settings. The Solacea(™) haemodialyser with an asymmetric triacetate membrane claims improved biocompatibility and has already shown promising results when use...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanommeslaeghe, Floris, Josipovic, Iván, Boone, Matthieu, van der Tol, Arjan, Dhondt, Annemie, Van Biesen, Wim, Eloot, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447252/
https://www.ncbi.nlm.nih.gov/pubmed/34548919
http://dx.doi.org/10.1093/ckj/sfaa219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447252/
https://www.ncbi.nlm.nih.gov/pubmed/34548919
http://dx.doi.org/10.1093/ckj/sfaa219

Ejemplares similares